NCT03061565 - Long Term Effects of Erythropoietin in Patients With Moderate to Severe Traumatic Brain Injury | Biotech Hunter

Enrollment

356

Participants

Timeline

Start Date

August 1, 2017

Primary Completion Date

July 1, 2022

Study Completion Date

December 31, 2022

Conditions

Traumatic Brain Injury

Interventions

DRUG

erythropoietin

Patients were given erythropoietin during the EPO-TBI study in 2010-2014. In the current follow-up we will evaluate any possible long term differences between patients treated with etrythropoietin compared to placebo.

DRUG

Placebos

Patients were given placebo during the EPO-TBI study in 2010-2014. In the current follow-up we will evaluate any possible long term differences between patients treated with etrythropoietin compared to placebo.

Trial Locations (1)

3004

Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne

All Listed Sponsors

collaborator

Monash University

OTHER

lead

Australian and New Zealand Intensive Care Research Centre

OTHER